Cargando…
The Multifunction Of miR-218-5p-Cx43 Axis In Breast Cancer
BACKGROUND: Gemcitabine is proven to be the first-line standard treatment of breast cancers. Yet, little is known involving gemcitabine resistance and remains largely to be elucidated. MATERIALS AND METHODS: We evaluated the expression of Cx43 in gemcitabine-resistant cells and parental cells by qua...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790128/ https://www.ncbi.nlm.nih.gov/pubmed/31632081 http://dx.doi.org/10.2147/OTT.S218524 |